Key takeaways
- GLP-1 users are spending an extra $100 to $300 per month out of pocket on supplements like fiber, electrolytes, and collagen to manage side effects.
- The surge in patient demand helped push the US dietary supplement market past $74 billion in sales in 2025.
- Because supplements do not require FDA preapproval, doctors are raising safety flags over unregulated marketing claims on platforms like TikTok.
- These secondary wellness and health costs significantly alter the true monthly budget for cash-pay telehealth buyers.
What happened
A growing number of GLP-1 patients in the United States are spending between $100 and $300 per month on dietary supplements to manage gastrointestinal side effects and nutritional deficiencies, according to a Reuters report detailing how weight-loss drugs are reshaping consumer spending. This auxiliary market has driven a massive surge in the dietary supplement industry, which surpassed $74 billion in sales in 2025. However, the rise of these self-prescribed supplement regimens has prompted medical experts and federal regulators to raise concerns over the lack of product oversight and safety data.
Why it matters
This secondary spending represents a massive, often unexpected cost for cash-pay telehealth buyers who initially only budget for the base price of their GLP-1 medications. While many consumers shop online for the cheapest telehealth GLP-1 plans, their true out-of-pocket costs can rise by $1,200 to $3,600 annually once they add supportive supplements like fiber, electrolytes, collagen, and protein powders.
For the estimated 10 million Americans who used GLP-1 drugs last year—a figure JPMorgan research projects could grow to 25 million by 2030—combating side effects like nausea, fatigue, muscle loss, and skin changes is becoming a costly necessity. Because dietary supplements do not require preapproval by the US Food and Drug Administration (FDA) to enter the market, buyers are left to navigate unregulated health claims, often relying on social media influencers rather than clinical guidance to manage their side effects.
What the data says
The data highlights a significant financial and regulatory shift driven by the side effects of GLP-1 medications:
- Surging Sales: US vitamin and supplement sales grew by 5% in 2024 and 7% in 2025, topping $74 billion last year, according to the Nutrition Business Journal.
- TikTok Shop Growth: TikTok Shop alone generated more than $1 billion in dietary supplement sales in 2025, accounting for 5.4% of all online supplement sales.
- The Monthly Toll: Patients interviewed by Reuters reported spending $110 to $300 per month out of pocket on supplements such as magnesium, electrolytes, B12, fiber, and collagen to manage nausea, extreme weakness, and constipation. These products are not covered by insurance.
- Broadening Consumer Impact: The side effects are changing spending across multiple sectors. Beyond supplements, emerging spending data from market research firm Circana shows households with a GLP-1 user spent 7% less per month on alcohol overall, and 13.5% less on beer specifically, after two years on the medication.
How it compares
For cash-pay patients comparing the costs of compounded vs brand name semaglutide, the added supplement bill can entirely erase the savings of choosing a cheaper provider. A patient paying $250 a month for compounded semaglutide through a telehealth platform might believe they are saving hundreds of dollars compared to the $1,000-plus retail price of brand-name Wegovy. However, if that patient must spend an additional $200 a month on protein shakes to prevent muscle wasting, electrolytes for dehydration, and fiber for severe constipation, their actual monthly healthcare budget climbs to $450.
Furthermore, these clinical side effects highlight a stark difference in how patients manage their care on telehealth platforms. Traditional weight-loss clinics often pair prescription GLP-1s with structured clinical nutrition plans. In contrast, many budget-friendly online platforms leave patients to self-manage symptoms. This gap has created a lucrative market for online supplement brands utilizing TikTok influencers—some licensed health professionals, others sharing "lived experience" on commission—to market unverified remedies directly to struggling patients.
How this fits the bigger picture
This surge in secondary wellness spending directly connects to earlier trends in the GLP-1 landscape. As weight-loss use increasingly overtakes diabetes treatment as the primary driver of these prescriptions, millions of consumers are entering the market without the intensive medical counseling traditionally provided to diabetic patients. We previously explored how this massive consumer shift reshapes retail, telehealth, and cash pricing math in our coverage of how GLP-1 weight loss use overtakes diabetes among telehealth buyers.
Furthermore, the physical side effects of rapid weight loss have already begun driving unexpected secondary bills in other areas of consumer spending. For instance, as patients look to treat "Ozempic face" and skin changes, major cosmetic companies have rushed to target these new physical concerns, a trend we analyzed in detail regarding how L'Oreal targets GLP-1 skin sagging, adding unexpected costs to patient budgets. Whether it is $300 a month for specialty skincare or $200 a month for dietary supplements, telehealth buyers must recognize that the "base price" of their weekly injection is rarely their final monthly cost.
What happens next
In response to the rapid rise in dietary supplement consumption, the FDA is currently weighing stricter ingredient oversight for these products. Additionally, medical researchers are calling for tighter regulations on how supplements are marketed online, particularly concerning the health claims made by social media influencers on platforms like TikTok.
For patients, the clinical community is expected to place a heavier focus on integrating standardized nutritional counseling into telehealth platforms. As the market for weight-loss therapies matures, telehealth providers may begin bundling supervised nutritional supplements directly into their monthly subscription prices to offer safer, more predictable pricing and care.
CompareRx does not provide medical advice. Always consult with a licensed healthcare provider before starting a GLP-1 medication or adding new dietary supplements to your routine.